Authors: Caldwell, SH Hespenheide, EE Harris, D De Lange, EE

Citation: Sh. Caldwell et al., Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis, J GASTR HEP, 16(2), 2001, pp. 220-224

Authors: Caldwell, SH Hespenheide, EE Redick, JA Iezzoni, JC Battle, EH Sheppard, BL

Citation: Sh. Caldwell et al., A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis, AM J GASTRO, 96(2), 2001, pp. 519-525

Authors: Struben, VMD Hespenheide, EE Caldwell, SH

Citation: Vmd. Struben et al., Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds, AM J MED, 108(1), 2000, pp. 9-13

Authors: Harris, DM Hespenheide, EE Dalkin, AC Kirk, SE Ellis, DS Caldwell, SH

Citation: Dm. Harris et al., Hyperthyroidism with interferon-ribavirin therapy for hepatitis C: A case report and proposed treatment algorithm, AM J GASTRO, 95(10), 2000, pp. 2995-2996

Authors: Caldwell, SH Oelsner, DH Iezzoni, JC Hespenheide, EE Battle, EH Driscoll, CJ

Citation: Sh. Caldwell et al., Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease, HEPATOLOGY, 29(3), 1999, pp. 664-669

Authors: Caldwell, SH Swerdlow, RH Khan, EM Iezzoni, JC Hespenheide, EE Parks, JK Parker, WD

Citation: Sh. Caldwell et al., Mitochondrial abnormalities in non-alcoholic steatohepatitis, J HEPATOL, 31(3), 1999, pp. 430-434